In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1 GAITHERSBURG, Md., Aug. 06, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc.,  and a recognized leader in genetic and genomic testing, announced the results...

GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019 GAITHERSBURG, Md., Feb. 28, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of OPKO Health, Inc.’s BioReference Laboratories, Inc. and recognized leader in genetic testing, joins the worldwide...